Income StatementBalance SheetCash FlowSegments
PLY

Polaryx Therapeutics, Inc. Cash Flow Statement

Operating, investing, and financing cash movements
Net Cash From Operating-$2.1MNet Cash From Financing$250.0K
Market Cap$161.4M

Operating

MetricQ1 '25Q1 '26
Change in accounts payable-$17.0K$380.0K
Net cash from operating activities-$709.0K-$2.1M
Net income-$5.1M-$2.5M
Due To Related Party—$7.0K
Increase Decrease In Accrued Liabilities Related Party—$22.0K
Other current liabilities-$87.0K—
Increase (Decrease) in Prepaid Expense and Other Assets$4.0K$395.0K
Stock-based compensation$4.5M$467.0K

Other

MetricQ1 '25Q1 '26
Net Change in Cash Excluding Exchange Rate Effect-45900000.0%-206300000.0%
Net Change in Cash Excluding FX Effect-$459.0K-$2.1M
Net Change in Cash Excluding Exchange Rate Effect-$459.0K-$2.1M

Financing

MetricQ1 '25Q1 '26
Net cash from financing activities$250.0K—
Proceeds from issuance of common stock$250.0K—